Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 21INDUSTRY 9NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Prostatic Neoplasms 23Breast Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 14Lymphoma 12Colorectal Neoplasms 12Neoplasms 10Melanoma 9Lung Neoplasms 9Leukemia, Myeloid, Acute 8Pancreatic Neoplasms 7Lymphoma, Non-Hodgkin 7Wilms Tumor 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 6Squamous Cell Carcinoma of Head and Neck 5Lymphoma, Mantle-Cell 5Hematologic Neoplasms 5Head and Neck Neoplasms 5HIV Infections 5Ependymoma 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Osteosarcoma 4Neoplasm Metastasis 4

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Stem Cell Transplantation 1Specimen Handling 1Melphalan 1Magnetic Resonance Spectroscopy 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Immunoglobulin Light-chain Amyloidosis × 90 days × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06649695 2026-04-21

A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

European Myeloma Network B.V.

Phase 2 Recruiting
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡